Cellu Tissue Holdings, Inc. (CLU) [Rocket]

In millions, except per share items	Feb-28-10	Feb-28-09	Feb-29-08	Feb-13-07	Mar-01-06	Feb-28-05	Feb-29-04	Feb-28-03
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
(Post-Merger)				247.4
Consolidated	511.3	519.0	443.1			332.9		232.4
Tissue	394.2	400.6	333.3					134.9
Machine-glazed paper	109.1	114.4	109.7					97.5
Total revenues	511.3	519.0	443.1	247.4	96.7	332.9	290.3	232.4
Revenue growth [+]	-1.5%	17.1%			-70.9%	14.7%	24.9%
Consolidated	-1.5%	17.1%
Tissue	-1.6%	20.2%
Machine-glazed paper	-4.7%	4.2%
Foam	99.4%
Cost of goods sold	432.2	464.1	401.4	234.9	88.6	292.1	256.9	200.9
Gross profit	79.1	54.9	41.7	12.5	8.2	40.8	33.3	31.5
Gross margin	15.5%	10.6%	9.4%	5.1%	8.5%	12.3%	11.5%	13.6%
Selling, general and administrative	22.6	21.9	20.0	7.2	4.7	14.6	13.4	13.2
Other operating expenses	4.3	2.9	2.1	4.5	6.9	4.3		0.1
EBITDA [+]	81.4	56.7	43.8	17.6	0.9		33.9	18.4
EBITDA growth	43.6%	29.5%			-95.9%	-35.2%	84.7%
EBITDA margin	15.9%	10.9%	9.9%	7.1%	0.9%	6.6%	11.7%	7.9%
Depreciation	24.9	23.7	24.1	16.8	4.2		14.0
EBITA	56.5	33.0	19.6	0.9	-3.3	22.0	19.9	18.4
EBITA margin	11.1%	6.4%	4.4%	0.3%	-3.4%	6.6%	6.9%	7.9%
Amortization of intangibles	4.3	2.9						0.1
EBIT [+]	52.2	30.2	19.6	0.9	-3.3	22.0	19.9	18.2
EBIT growth	73.0%	53.7%			-115.2%	10.1%	9.4%
EBIT margin	10.2%	5.8%	4.4%	0.3%	-3.4%	6.6%	6.9%	7.8%
Non-recurring items				0.2
Interest expense	39.6	24.7	19.9	11.5	4.9	17.4	7.1	2.4
Interest expense	39.6	24.7	19.9	11.5	4.9	17.4	7.1	2.4
Other income (expense), net [+]	-1.3	0.5	0.0	0.0	-0.1	-1.5	-0.6	10.9
Gain (loss) on foreign currency transactions	0.0	0.1	-0.1			0.6	0.7	0.3
Other						2.4	0.1	-0.1
Pre-tax income	11.3	5.9	-0.2	-10.8	-8.3	3.0	12.3	26.7
Income taxes	7.5	-0.6	-3.9	-4.2	-1.9	-0.1	5.2	11.0
Tax rate	66.7%		1882.6%	38.6%	22.7%		41.9%	41.1%
Net income	3.8	6.6	3.7	-6.7	-6.4	3.1	7.1	15.7
Net margin	0.7%	1.3%	0.8%	-2.7%	-6.7%	0.9%	2.5%	6.8%

Basic EPS [+]	$0.21	$0.38	$0.21
Growth	-43.4%	77.2%
Diluted EPS [+]	$0.21	$0.38	$0.21
Growth	-43.5%	77.2%

Shares outstanding (basic) [+]	17.7	17.4	17.4
Growth	1.4%	0.0%
Shares outstanding (diluted) [+]	17.7	17.4	17.4
Growth	1.5%	0.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.